SG11202105739YA - New form of isoquinoline sulfonamide - Google Patents
New form of isoquinoline sulfonamideInfo
- Publication number
- SG11202105739YA SG11202105739YA SG11202105739YA SG11202105739YA SG11202105739YA SG 11202105739Y A SG11202105739Y A SG 11202105739YA SG 11202105739Y A SG11202105739Y A SG 11202105739YA SG 11202105739Y A SG11202105739Y A SG 11202105739YA SG 11202105739Y A SG11202105739Y A SG 11202105739YA
- Authority
- SG
- Singapore
- Prior art keywords
- new form
- isoquinoline sulfonamide
- isoquinoline
- sulfonamide
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018235213 | 2018-12-17 | ||
| PCT/JP2019/049099 WO2020129876A1 (en) | 2018-12-17 | 2019-12-16 | Novel form of isoquinolinesulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105739YA true SG11202105739YA (en) | 2021-07-29 |
Family
ID=71101331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105739YA SG11202105739YA (en) | 2018-12-17 | 2019-12-16 | New form of isoquinoline sulfonamide |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11427546B2 (en) |
| EP (1) | EP3901141B1 (en) |
| JP (1) | JP7425482B2 (en) |
| KR (1) | KR20210104729A (en) |
| CN (1) | CN113195453B (en) |
| AU (1) | AU2019402422A1 (en) |
| BR (1) | BR112021011739A2 (en) |
| CA (1) | CA3120751A1 (en) |
| DK (1) | DK3901141T3 (en) |
| EA (1) | EA202191339A1 (en) |
| FI (1) | FI3901141T3 (en) |
| MX (1) | MX2021007233A (en) |
| PT (1) | PT3901141T (en) |
| SG (1) | SG11202105739YA (en) |
| WO (1) | WO2020129876A1 (en) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1370914A (en) | 1971-07-06 | 1974-10-16 | Ici Ltd | Paint compositions |
| DE3943678C2 (en) * | 1988-12-26 | 1999-11-25 | Hiroyoshi Hidaka | New isoquinoline:sulphonamide and naphthalene:sulphonamide cpds. |
| US5340811A (en) | 1990-03-08 | 1994-08-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same |
| DE69606721T2 (en) | 1995-07-03 | 2000-06-21 | Asahi Chemical Ind | 1- (5-ISOCHINOLINSULFONYL) HOMOPIPERAZINE HYDROCHLORIDE |
| JP2899953B2 (en) | 1995-07-03 | 1999-06-02 | 旭化成工業株式会社 | 1- (5-isoquinoline sulfonyl) homopiperazine hydrochloride hemihydrate |
| MY139797A (en) | 2004-11-29 | 2009-10-30 | Kowa Co | (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate |
| ES2396795T3 (en) | 2007-07-02 | 2013-02-27 | Asahi Kasei Pharma Corporation | Sulfonamide compound and cirstal thereof |
| PT2657227T (en) * | 2010-12-22 | 2016-08-01 | D Western Therapeutics Inst Inc | Novel substituted isoquinoline derivative |
| JP5819705B2 (en) | 2011-11-09 | 2015-11-24 | 興和株式会社 | Isoquinoline derivative hydrochloride anhydrous crystals |
-
2019
- 2019-12-16 WO PCT/JP2019/049099 patent/WO2020129876A1/en unknown
- 2019-12-16 FI FIEP19899054.1T patent/FI3901141T3/en active
- 2019-12-16 EP EP19899054.1A patent/EP3901141B1/en active Active
- 2019-12-16 CN CN201980082942.XA patent/CN113195453B/en active Active
- 2019-12-16 KR KR1020217019115A patent/KR20210104729A/en unknown
- 2019-12-16 SG SG11202105739YA patent/SG11202105739YA/en unknown
- 2019-12-16 BR BR112021011739-3A patent/BR112021011739A2/en unknown
- 2019-12-16 AU AU2019402422A patent/AU2019402422A1/en active Pending
- 2019-12-16 MX MX2021007233A patent/MX2021007233A/en unknown
- 2019-12-16 US US17/296,439 patent/US11427546B2/en active Active
- 2019-12-16 JP JP2020561396A patent/JP7425482B2/en active Active
- 2019-12-16 PT PT198990541T patent/PT3901141T/en unknown
- 2019-12-16 DK DK19899054.1T patent/DK3901141T3/en active
- 2019-12-16 EA EA202191339A patent/EA202191339A1/en unknown
- 2019-12-16 CA CA3120751A patent/CA3120751A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3901141A4 (en) | 2022-07-13 |
| FI3901141T3 (en) | 2024-03-01 |
| WO2020129876A1 (en) | 2020-06-25 |
| JP7425482B2 (en) | 2024-01-31 |
| CA3120751A1 (en) | 2020-06-25 |
| EA202191339A1 (en) | 2021-08-27 |
| MX2021007233A (en) | 2021-07-15 |
| EP3901141B1 (en) | 2024-02-07 |
| US11427546B2 (en) | 2022-08-30 |
| CN113195453B (en) | 2024-04-30 |
| DK3901141T3 (en) | 2024-02-26 |
| JPWO2020129876A1 (en) | 2021-11-04 |
| EP3901141A1 (en) | 2021-10-27 |
| KR20210104729A (en) | 2021-08-25 |
| US20220017469A1 (en) | 2022-01-20 |
| BR112021011739A2 (en) | 2021-08-31 |
| AU2019402422A8 (en) | 2021-07-01 |
| PT3901141T (en) | 2024-03-04 |
| AU2019402422A1 (en) | 2021-06-17 |
| CN113195453A (en) | 2021-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272555A (en) | Novel sulfonamide carboxamide compounds | |
| IL273786A (en) | Novel sulfonamide carboxamide compounds | |
| IL271716A (en) | Novel sulfonamide carboxamide compounds | |
| IL272550A (en) | Novel sulfonamide carboxamide compounds | |
| ZA201904500B (en) | Separate configuration of numerology-associated resources | |
| ZA202004424B (en) | Radiolabeling of polypeptides | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| IL274627A (en) | Solid state form of valbenazine | |
| DK3737677T3 (en) | TETRAHYDROISOQUINOLINE COMPOUNDS | |
| GB201806072D0 (en) | Methods of manufacture | |
| EP3894768C0 (en) | Methods of cryo-curing | |
| GB201805904D0 (en) | Methods of Manufacture | |
| GB201906176D0 (en) | Gating of radiotherepy | |
| GB2588505B (en) | Preparation of psilocybin | |
| GB2575067B (en) | Selection of identifiers | |
| ZA202105399B (en) | Use of spiropidion | |
| SG11202105739YA (en) | New form of isoquinoline sulfonamide | |
| IL276107A (en) | Solid forms of fasoracetam | |
| SG11202105136WA (en) | Application of chidamide | |
| GB201814356D0 (en) | Methods of detergents | |
| IL254666A0 (en) | Solid state form of eldecalcitol | |
| IL283421A (en) | Solid state forms of reproxalap | |
| GB201810835D0 (en) | Methods of use | |
| GB201817193D0 (en) | Tetrahydroisoquinoline compounds | |
| PL3511335T3 (en) | Manufacture of metallasilisesquioxanes |